Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2280]
News [5219]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Adjuvant endocrine therapy +/- 1 year of everolimus fails to improve iDFS and...
Dr Mariana Chavez Mac Gregor - MD Anderson Cancer Center, Houston, USA
Adjuvant endocrine therapy +/- 1 year of everolimus fails to improve iDFS and OS in patients with high-risk HR+, HER2-negative BC ( Dr Mariana Chavez Mac Gregor - MD Anderson Cancer Center, Houston, USA )
14 Dec 2022
Opinion: Premature regulatory approval by the FDA
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Opinion: Premature regulatory approval by the FDA ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
13 Dec 2022
Polatuzumab vedotin combined with R-ICE as second-line therapy gives favourable...
Dr Matthew Matasar - Rutgers Cancer Institute, New Brunswick, USA
Polatuzumab vedotin combined with R-ICE as second-line therapy gives favourable results against R/R diffuse large B-cell lymphoma ( Dr Matthew Matasar - Rutgers Cancer Institute, New Brunswick, USA )
12 Dec 2022
Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows...
Dr Emma Searle - University of Manchester, Manchester, UK
Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows promising results in patients with multiple myeloma ( Dr Emma Searle - University of Manchester, Manchester, UK )
12 Dec 2022
The future of precision oncology
Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany
The future of precision oncology ( Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany )
7 Dec 2022
The concept of pan-tumour therapeutics
Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany
The concept of pan-tumour therapeutics ( Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany )
7 Dec 2022
Access to Oncology Medicines Coalition - The Medicines Patent Pool
Charles Gore - Medicines Patent Pool, Geneva, Switzerland
Access to Oncology Medicines Coalition - The Medicines Patent Pool ( Charles Gore - Medicines Patent Pool, Geneva, Switzerland )
1 Dec 2022
Systemic anti-cancer performance matrix
Prof Richard Sullivan, Kari Leung and Megan McLeod
Systemic anti-cancer performance matrix ( Prof Richard Sullivan, Kari Leung and Megan McLeod )
23 Nov 2022
Developing low cost therapies: Practical tips
Prof Ian Tannock - Princess Margaret Cancer Centre, Toronto, Canada
Developing low cost therapies: Practical tips ( Prof Ian Tannock - Princess Margaret Cancer Centre, Toronto, Canada )
27 Oct 2022
Isatuximab Subgroup Data Analyses Show Opportunity for Durable Responses in...
Prof Evangelos Terpos, Dr Marcelo Capra, Dr Fredrik Schjesvold, and Prof...
Isatuximab Subgroup Data Analyses Show Opportunity for Durable Responses in Elderly, Frail, and Renally Impaired Patients With RRMM ( Prof Evangelos Terpos, Dr Marcelo Capra, Dr Fredrik Schjesvold, and Prof Meletios Dimopoulos )
27 Oct 2022
Complex technologies for advanced diagnosis and precision medicine in oncology
Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Complex technologies for advanced diagnosis and precision medicine in oncology ( Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
24 Oct 2022
Genomic testing in biliary tract cancers
Dr Chiara Braconi - University of Glasgow, Glasgow, UK
Genomic testing in biliary tract cancers ( Dr Chiara Braconi - University of Glasgow, Glasgow, UK )
24 Oct 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation